The ambulatory surgical centers (ascs) market size was approximately $90 billion in 2024 and is expected to grow to $140 billion by 2030, at a CAGR of 7.5%. Factors driving this growth include the growth of the global population with surgical needs, especially the aging population, increasing rat... Read More
The ambulatory cardiac monitoring devices market was valued at approximately $3.2 billion in 2024 and is projected to reach $5.1 billion by 2030, growing at a CAGR of 7.9% during ... Read More
The surgical retractors market was $3.2 billion in 2024 and will reach $5.1 billion by 2030 at a CAGR of 8.1% during the forecast period. The advancements in surgical instruments, global surgical rate, and growing healthcare expenditures drive its market growth.
The Sur... Read More
The RSV Diagnostics Market revenue size was $2.1 billion in 2024 and, at a CAGR of 12.3%, will be $4.3 billion by 2030. The growing rate of RSV infection in children, the mature, and patients with immune deficiency drives demand for effective diagnostics at the early stages.
Medical Imaging Outsourcing Market Overview: Growth Trends and Future Projections.
The medical imaging outsourcing market was $3.8 billion in 2024 and will rise to $6.7 billion by 2030 at a CAGR of 9.4%. Technological enhancements, pressure on healthcare facilities and ... Read More
The pulsed field ablation market was $200 million globally in 2023 and projected to reach $900 million with a compound annual growth rate of 22.8%, by 2030. The market is expanding due to factors such as growing rate of atrial fibrillation, innovation in ablation technology, and the growing prefe... Read More
The global medical electrodes market was estimated at about $1.2 billion in 2023 and will reach $2.1 billion at a CAGR of 7.4% by 2.030 Factors helping this market expand include growing cases of chronic diseases, improved technology in electrode materials, technology used in electrodes and the g... Read More
The in vivo cro market was $5,198 million in 2024 and will reach $9,140 million by 2030 at a CAGR of 9.8%. Pharmaceutical R&D development, enhancing regulatory demands for drug approval, and an escalating... Read More
The market size of ERCP was USD 1.4 billion in 2023 and will be USD 2.2 billion by 2030, at a CAGR of 6.8%. Such growth is attributed to the expanding incidence of pancreaticobiliary diseases, the growing need for minimally invasive diagnostic methods, and developments in endoscopies.
&... Read More
The uterine fibroids treatment devices market was USD 4.8 billion in 2023 and is expected to reach USD 8.2 billion by 2030 at an average CAGR of 7.8% by the end of the projections period. Market growth is propelled by new developments in the medical field, growing consciousness of female health, ... Read More